Chemring Group PLC Transaction in Own Shares

RNS Number : 3343E

Chemring Group PLC

26 February 2024

 

26^th February 2024                                             

Chemring Group PLC

("Chemring" or the "Company")

Transaction in Own Shares

 

Chemring Group PLC ("Chemring" or the "Company") announces it has purchased the following number of its ordinary shares of 1 pence each through Investec Bank plc.

Ordinary Shares

Date of purchase:	23rd February 2024
Number of ordinary shares purchased:	25,563
Lowest price per share (pence):	349.5
Highest price per share (pence):	350.0
Weighted average price per day (pence):	349.9948

 

The Company intends to cancel the purchased shares.

 

 

The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 1 August 2023 (the "Programme").

  

Aggregate information:

Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
XLON	349.9948	25,563	349.50	350.00

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Investec on behalf of the Company as part of the Programme is detailed below:

 

Date and time of each trade	Number of shares purchased	Price (pence per share)	Trading Venue	Transaction Reference Number
23 February 2024 15:47:42	38	350.00	XLON	00259944505TRLO1
23 February 2024 16:06:04	38	350.00	XLON	00259945039TRLO1
23 February 2024 16:06:04	219	350.00	XLON	00259945038TRLO1
23 February 2024 16:06:04	25,000	350.00	XLON	00259945041TRLO1
23 February 2024 16:06:04	268	349.50	XLON	00259945040TRLO1

 

For further information:

Rupert Pittman	Group Director of Corporate Affairs, Chemring Group PLC	[phone]
James McFarlane	MHP Communications	[phone]
Ollie Hoare

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSSELFMDELSELE